COMP <GO>
NOV vs AMZN // RSI-14 & 200D SMA MOMENTUM
NOV Inc. (NYSE) VS. Amazon.com, Inc. (NASDAQ) • 15-METRIC TALLY: NOV 4
— AMZN 6
▲ RSI-14 & 200D SMA MOMENTUM LEADER: NOV
LAST: $19.29 (-0.36%) • MKT CAP: $6.90B
rsi-technicals
48.3
LAST: $240.35 (-1.41%) • MKT CAP: $2.59T
rsi-technicals
38.3
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NOV VS. AMZN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NOV | AMZN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.20% | — | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.10% | 17.61% | -11.51 | AMZN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 8.7x | 15.8x | -7.05 | NOV | /valuation <GO> |
| Free Cash Flow Yield | 12.69% | -1.81% | +14.50 | NOV | /fcf-yield <GO> |
| Operating Margin | 5.60% | — | — | TIE | /operating-margins <GO> |
| Net Profit Margin | 1.70% | — | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -1.40% | — | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 2.75% | 0.00% | +2.75 | NOV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.03 | 3.32 | -1.29 | AMZN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 6/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.30% | 6.73% | +0.57 | AMZN | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 48.3 | 38.3 | +9.99 | NOV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.11 | 1.46 | -0.35 | AMZN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 44.3x | 22.8x | +21.55 | AMZN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $6.90B | $2.59T | -$2.59T | AMZN | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NOV REV | AMZN REV | NOV GROSS % | AMZN GROSS % | NOV FCF | AMZN FCF |
|---|---|---|---|---|---|---|
| FY 2026 | — | $0 | — | — | — | -$46.89B |
| FY 2025 | $8.74B | $0 | 20.2% | — | $876.0M | $10.56B |
| FY 2024 | $8.87B | $0 | 22.7% | — | $953.0M | $42.95B |
| FY 2023 | $8.58B | $0 | 44.0% | — | -$243.2M | $16.92B |
| FY 2022 | — | $0 | — | — | — | -$26.32B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NOV // BETA 1.11
AMZN // BETA 1.46